ISPOR - Economic Cost of Adverse Events Per Course of Therapy with Commonly Used First-Line Regimens for the Treatment of Chronic Lymphocytic Leukemia

Full Text

Economic Cost of Adverse Events Per Course of Therapy with Commonly Used First-Line Regimens for the Treatment of Chronic Lymphocytic Leukemia

Abstract

Authors

M.J. Monberg A. Shukla H.V. Le T. Lin G. Bonifacio

Back to Volume 17, Issue 3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now